|Bid||1.3500 x 0|
|Ask||1.3700 x 0|
|Day's Range||1.3250 - 1.4200|
|52 Week Range||1.1100 - 6.2200|
|Beta (5Y Monthly)||2.99|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 09, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.92|
Did you know that in five years, shares of Aurora Cannabis (NASDAQ: ACB) have plunged an incredible 99%? In 2020, the company did a 1-for-12 reverse stock split to help get it comfortably up over $1 to stay listed on the NYSE and to give it a bit of a buffer as well, presumably so it wouldn't need to do another reverse split for some time. It would require a copious amount of optimism to be bullish on Aurora's prospects right now.
There's more evidence now favoring medical marijuana legalization. But medical marijuana is already legal in most states.
Here is how Aurora Cannabis Inc. (ACB) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.